Obesity drugs will not solve our billion-person problem, warns WHO

March 01, 2024

By Naomi Kresge and Angela FelicianoEffective, popular obesity medications won’t be enough to solve a worldwide problem that now affects more than 1 billion people, World Health Organization officials warned. While rates of obesity have leveled off in some wealthy countries — particularly in Europe — the research team found rapid increases in low- and middle-income countries. The problem of low weight due to malnourishment has been replaced by obesity as a leading issue in many nations, the team said, in a study published in The Lancet. New obesity drugs such as Novo Nordisk A/S’s Wegovy and Eli Lilly & Co.’s Zepbound could be an $80 billion market by 2030. They found that more than 879 million adults and 159 million children probably had obesity in 2022.